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Abstract
Introduction: The fungi Malassezia are a constituent of the skin microbiota in humans and some animals. The fungi
may cause skin diseases or even organ and/or generalized infections in the presence of appropriate predisposing
factors.
Aim: To evaluate the occurrence of Malassezia fungi on the skin in patients with psoriasis and search for a rela-
tionship between the occurrence of Malassezia and the severity of skin lesions, age and sex of the patients.
Material and methods: The materials comprised smears sampled from four sites: scalp, face, chest and back.
Malassezia spp. were isolated in cultures on modified Dixon medium and identified on the basis of morphological
and biochemical features. 
Results: Malassezia spp. were isolated in 55.1% of the patients. The fungi were most prevalent on the back (33.3%)
and least on the scalp (17.5%) and face (19%). The prevalence on the chest was 30.2%. In the group of patients with
AD localized to the head and neck Malassezia spp. were cultured in 71.4% of patients.
Conclusions: No statistically significant differences were found between Malassezia prevalence in males vs. females.
No relationship with the patients’ age was found. Higher values of the atopic dermatitis severity index (SCORAD)
were found in the patients in whom Malassezia spp. were isolated. Malassezia spp. were particularly common in
the group of patients with AD localized to the head and neck.
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Introduction
The fungi Malassezia are opportunists of significant
clinical importance in humans and in animals. Malassezia
spp. may be isolated from healthy human and animal skin.
These fungi are involved in certain dermatological dis-
eases and, in the case of considerable immunological
insufficiency, they can cause systemic infections [1-6]. Cur-
rently, by techniques of molecular biology, 13 Malassezia
species were identified, with 12 lipid-dependent species
(M. furfur, M. globosa, M. obtusa, M. sympodialis, M. sloof-
fiae, M. nana, M. dermatis, M. restricta, M. equina,
M. japonica, M. yamatoensis and M. caprae) and one lipid-
independent species (M. pachydermatis) among them [1,
6-9]. Frequency of the superficial fungal infections caused
by species of the Malassezia genus depends on many dif-
ferent factors, such as socio-economic, climatic or geo-
graphical factors [10].
Atopic dermatitis (AD) is a chronic recurrent pruritic
dermatosis, affecting mainly children. Atopic dermatitis
may occur as an isolated disease or as a manifestation of
a systemic allergic disorder, together with hay fever,
bronchial asthma or food allergies. Atopic dermatitis is
also observed in 1-3% of adults. The disease may occur for
the first time in adulthood, persist from childhood or recur
after a long period of remission [11-13]. Malassezia spp.
seem to be an important factor in the pathogenesis of AD
in adults, particularly when the skin lesions are localized
to the head and neck. Since the 1980s it has been observed
that the skin lesions in patients with AD disappear after
the administration of local and systemic antifungal agents
[14]. The prevalence of Malassezia spp. on the skin of adult
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patients with AD compared to the healthy population is
similar and is between 50% and 80%, depending on the
testing method. However, it was noticed that in patients
with AD, positive results of skin tests with Malassezia spp.
allergens and high plasma levels of specific IgE antibodies
against Malassezia spp. are found significantly more often
than in the control groups [15-17]. Therefore, currently,
Malassezia spp. are considered to be an allergenic rather
than an infectious agent, in the case of patients with AD.
Exacerbation of the skin lesions in patients with AD may
occur also as a result of activation of inflammatory reac-
tions by the release of hydrolytic enzymes by Malassezia
spp. [18, 19].
Aim
The objective of the study was to evaluate the occur-
rence of Malassezia fungi on the skin in patients with pso-
riasis and search for a relationship between the occur-
rence of Malassezia and the severity of skin lesions, age
and sex of the patients.
Material and methods
Experimental group
The experimental group consisted of adult patients
of both sexes, who were diagnosed with atopic dermati-
tis according to the criteria of Hanifin and Rajka. Clinical
condition of the patients was assessed using SCORAD
(Severity Scoring of Atopic Dermatitis). Isolation and iden-
tification of Malassezia spp.
Material for the mycological examination was
obtained from each patient using sterile swabs moist-
ened with saline. Smears were sampled from four sites
of the body: 1) scalp, 2) face (nasolabial grooves and fore-
head), 3) chest (sternal region), 4) back (interscapular
region). The material was inoculated on modified Dixon
medium, which was composed of: malt extract 36 g, pep-
tone 6 g, ox bile 20 g, Tween 40 10 ml, glycerol 2 ml, 
oleic acid 2 ml, chloramphenicol 250 mg, agar 12 g, dis-
tilled water 1000 ml. Cultures were incubated at 30°C for
10 days. Fungi were identified to the level of species on
the basis of the colony morphology, microscopic appear-
ance of the fungal cells obtained in the culture, by exam-
ining the ability of the fungi to grow without addition of
lipids and by performing the urease test on Christensen’s
solid medium (with Tween 40 and Tween 80).
Results
The obtained data were analysed using the program-
ming language and software environment for statistical
computing R (version 2.9.1, 2009).
The study included 49 patients (29 women and 
20 men) with atopic dermatitis, aged between 18 and 69.
The results are presented in the Table 1 and in the Figure 1.
Malassezia spp. were isolated from 27 patients (55.1%),
including 16 women (55.2%) and 11 men (55%). In total,
63 isolates of Malassezia spp. were obtained from differ-
ent body locations (37 from women and 26 from men).
No statistically significant difference was observed in the
frequency of isolation of Malassezia spp. between women
and men (χ2 test, p = 0.9905).
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Tab. 1. Characteristics of patients included in the study
Sex Number Age, x ± SD Number of Malassezia spp. isolates from particular skin regions SCORAD, x ± SD (Me)
Scalp Face Chest Back
F 29 34.3 ±13.8 7 8 11 11 42.1 ±16.7 (42.5)
M 20 31.9 ±12.2 4 4 7 10 38.8 ±16.5 (36.5)
Σ 49 33.3 ±13.1 11 12 18 21 40.8 ±16.5 (38.7)
F – female, M – male, x ± SD – mean ± standard deviation, Me – median
Fig. 1. Comparison of the SCORAD index values in patients
with and without Malassezia skin colonization. M(–)/F(–) –
male/female without Malassezia skin colonization, M(+)/F(+)
– male/female with Malassezia skin colonization. The box
represents 1-3 quartiles, the median is marked by a hori-
zontal line, the range value by whiskers, the outliers by
a circle
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Predominantly, Malassezia spp. were isolated from the
interscapular region. Overall, 21 isolates were obtained
from this site (33.3% of all isolates of Malassezia spp.): 
11 isolates from women and 10 isolates from men. Least
frequently, Malassezia spp. were isolated from the scalp
(11 isolates – 17.5%) and only slightly more often from the
seborrhoeic regions of the face (12 isolates – 19.0%). This
tendency was seen in both women and men. However, in
patients with particularly severe skin lesions on the skin
of the head and neck, in the course of AD, Malassezia spp.
were isolated from these sites in 71.4% of cases. From the
skin of the chest, Malassezia spp. were isolated in 30.2%
of the patients (11 isolates from women and 8 isolates
from men). In 74.1% of the included patients in whom
Malassezia spp. were found (68.7% women and 81.8%
men), these fungi could be isolated from at least 2 dif-
ferent sites of the body. In 18.5% of the patients (25%
women and 9% men), Malassezia spp. were found in all
examined locations, at the same time. 
In the study, no difference in the frequency of occur-
rence of Malassezia spp. depending on the age of the
patients could be seen (Student's t-test, p = 0.3656).
Severity of skin lesions and subjective symptoms (pru-
ritus, sleep disorder) in the course of AD expressed by the
SCORAD index was between 10.2 and 80 (mean 40.8).
Higher values of the SCORAD index were seen in the
group in which Malassezia spp. could not be found (Mann-
Whitney test, p = 0.004347). In patients with severe AD
(SCORAD index above 40) Malassezia spp. were isolated
in 43.5% of the patients, whereas in the group with the
SCORAD index below 40, the fungi were isolated from
65.4% of the patients.
Discussion
The role of Malassezia spp. in AD has been studied
since the beginning of the 1980s, when it was observed
that the skin lesions in this dermatosis disappear after the
administration of antifungal agents [14]. It was found that
fungi of the Malassezia genus, on the one hand, can be
a component of the normal flora in healthy people, and on
the other hand can act as an allergen and be a direct infec-
tious factor causing superficial and systemic fungal infec-
tions [20, 21]. Clemmensen et al., examining patients with
skin lesions on the face and neck and with concomitant
pruritus, observed positive reactions in the skin prick tests
with M. furfur antigen [14]. Many clinical trials confirm the
presence of specific IgE antibodies against Malassezia spp.
antigens in the plasma in patients with AD [15-17]. The fre-
quency of occurrence of Malassezia spp. on the skin in
patients with AD and in the healthy population is similar
and varies between 50% and 80%. These differences are
due to the testing method. In our study Malassezia spp.
were isolated from 55.1% of the patients with atopic der-
matitis, most frequently from the interscapular region
(33.3%). Similar results were obtained by Nakabayashi et al.
and Yim et al. [22, 23]. In the first of the cited studies, pos-
itive culture results were obtained in 54% of the samples
from patients with AD and in 50% of the samples from
healthy people [22]. In the latter one, Yim et al. obtained
positive culture results in the case of 51.7% of the patients
with AD (the 26S rDNA PCR-RFLP method was used) [23].
The species most frequently isolated was M. sympodialis
(16.3%). There were significant differences in the occur-
rence of particular species, depending on the site of sam-
pling. In samples obtained from the scalp and the face,
M. restricta was isolated most often (30% and 16.7% respec-
tively), whereas in samples from the skin of the chest,
M. sympodialis was found most frequently (28.3%). In the
study conducted by Nakabayashi, predominantly isolated
species were M. globosa (22%) and M. furfur (17%). Ma las -
sezia furfur was isolated more often from the sites where
skin lesions were observed (21%) than from the unchanged
skin (11%) [22]. In our study, in the group with particularly
severe skin lesions on the head and neck, positive culture
results for Malassezia spp. were obtained in samples from
the mentioned sites in the case of 71.4% of the patients. 
In the study, positive culture results for Malassezia
spp. were more frequent in the case of patients with less
severe AD (SCORAD index below 40) compared to the
patients with severe AD. A possible reason for that could
be a significantly decreased level of skin lipids in the lat-
ter group of patients. In the quantitative studies, it was
found that in patients with severe AD, the number of
colonies of Malassezia spp. was lower in the case of iso-
lates from skin lesions compared to isolates from the
unchanged skin [24]. Another explanation for this phe-
nomenon could be intensified migration of the inflam-
matory cells to the skin and high concentrations of
released mediators having antifungal properties in
patients with severe AD [23].
The results of the study suggest that Malassezia is an
allergenic rather than an infectious agent in patients with
AD. It is worth stressing the role of particular species of
the Malassezia genus in patients with skin lesions in 
different locations. Studies on the pathogenicity of
Malassezia spp. have been conducted in the Department
of Mycology since the 1980s [25-30]. In order to specify
the exact role of Malassezia spp. in patients with AD, appli-
cation of molecular biology methods is necessary. The
characteristics of particular strains will be a subject of
further studies in our department.
The study was done at the Department of Mycology,
Chair of Microbiology, Jagiellonian University, Collegium
Medicum, Krakow.
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